Showing results (61-70 of 81) with videos related to
Sort By:
Pageof 9
The American Journal of Physiology|July 31, 1998
Effects of ACE inhibition on cardiomyocyte apoptosis in dogs with heart failureA Goussev, V G Sharov, H Shimoyama, et al.The Annals of Thoracic Surgery|November 18, 2000
Passive epicardial containment prevents ventricular remodeling in heart failureP A Chaudhry, T Mishima, V G Sharov, et al.The American Journal of Physiology|April 13, 1999
Effects of AT1-receptor blockade on progression of left ventricular dysfunction in dogs with heart failureM Tanimura, V G Sharov, H Shimoyama, et al.Hypertension (Dallas, Tex. : 1979)|January 1, 1996
Paracrine systems in the cardioprotective effect of angiotensin-converting enzyme inhibitors on myocardial ischemia/reperfusion injury in ratsY H Liu, X P Yang, V G Sharov, et al.Virchows Archiv. B, Cell Pathology Including Molecular Pathology|January 1, 1989
Ultrastructure of Purkinje cells in the subendocardium and false tendons in early experimental myocardial infarction complicated by fibrillation in the dogV G Sharov, N N Beskrovnova, S A Kryzhanovsky, et al.International Journal of Cardiology|March 1, 1994
Abnormalities of contractile structures in viable myocytes of the failing heartV G Sharov, H N Sabbah, H Shimoyama, et al.The Journal of Clinical Investigation|April 15, 1997
Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptorsY H Liu, X P Yang, V G Sharov, et al.The American Journal of Physiology|December 1, 1993
Ventriculographic evaluation in three rat models of cardiac dysfunctionX P Yang, H N Sabbah, Y H Liu, et al.The Journal of Thoracic and Cardiovascular Surgery|November 1, 1987
Protection of ischemic myocardium by exogenous phosphocreatine. I. Morphologic and phosphorus 31-nuclear magnetic resonance studiesV G Sharov, V A Saks, V V Kupriyanov, et al.Circulation|October 18, 2000
Effects of dopamine beta-hydroxylase inhibition with nepicastat on the progression of left ventricular dysfunction and remodeling in dogs with chronic heart failureH N Sabbah, W C Stanley, V G Sharov, et al.Pageof 9